AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
BC
Bio
Professional summary
Brendan Weber is a Principal on OrbiMed's Credit & Royalty team, focused on structured credit and royalty-based financings. He joined OrbiMed in 2017 after roles at Moody's Investors Service, where he covered investment-grade and high-yield pharmaceuticals, and Johnson & Johnson's Medical Devices & Diagnostics division. He holds a B.S. in Biology from The College of New Jersey and is a CFA charter holder.
Background
Career, education, and skills
Career history
- OrbiMedPrincipal, Credit & Royalty2017 – Present
- Moody's Investors ServiceAnalyst, pharmaceutical sector
- Johnson & JohnsonMedical Devices & Diagnostics division
Education
- The College of New JerseyB.S. in Biology
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.
David Wang
Partner
OrbiMed
OrbiMed Asia Partner focused on Greater China healthcare investments.